UNITEDHEALTH GROUP INC (UNH) — Company Valuation Lab

Period

History

Units

At a glance

FY2025

Missing values remain blank—not zero.

Revenue

Canonical revenue for the selected period.

reported · Revenues

$447.57B

11.8% vs prior

Revenue growth

Change from the comparable prior fiscal period.

derived · year_over_year_growth

11.8%

+4.1 pts vs prior

Gross profit

Revenue less reported cost of revenue when available.

—

Unavailable

Operating income

Income from operations before non-operating items.

reported · OperatingIncomeLoss

$18.96B

(41.3%) vs prior

Net income

Net income attributable under the selected SEC concept.

reported · NetIncomeLoss

$12.06B

(16.3%) vs prior

Operating cash flow

Cash provided by or used in operating activities.

reported · NetCashProvidedByUsedInOperatingActivities

$19.7B

(18.6%) vs prior

Free cash flow

Operating cash flow less normalized positive CapEx outflow.

derived · operating_cash_flow_minus_capex

$16.08B

(22.4%) vs prior

Cash

Cash and cash equivalents at the period end.

reported · CashAndCashEquivalentsAtCarryingValue

$24.37B

(3.7%) vs prior

Total debt

Current and noncurrent debt, only when both components exist.

—

Unavailable

Equity

Reported stockholders’ equity at period end.

reported · StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

$100.09B

1.9% vs prior

Diluted shares

Reported weighted-average diluted shares for the period.

reported · WeightedAverageNumberOfDilutedSharesOutstanding

911M

(1.9%) vs prior

Gross margin

Gross profit divided by positive revenue.

—

Unavailable

Show additional ratios and quality metrics

Operating margin

Operating income divided by positive revenue.

derived · divide

4.2%

-3.8 pts vs prior

Net margin

Net income divided by positive revenue.

derived · divide

2.7%

-0.9 pts vs prior

FCF margin

Free cash flow divided by positive revenue.

derived · divide

3.6%

-1.6 pts vs prior

3Y revenue CAGR

Compound annual revenue growth over three fiscal years.

derived · three_year_compound_annual_growth

11.4%

-0.3 pts vs prior

Current ratio

Current assets divided by positive current liabilities.

derived · divide

0.79×

(4.6%) vs prior

Debt / equity

Total debt divided by positive stockholders’ equity.

—

Unavailable

ROIC proxy

NOPAT proxy divided by debt plus equity less cash.

—

Unavailable

FCF consistency

Share of recent observed periods with positive FCF.

derived · positive_periods_divided_by_observed_periods

100.0%

+0.0 pts vs prior

Revenue and profit trend

Revenue, operating income, and net income on a common scale.

Revenue Operating income Net income

Margin trend

Profitability and cash conversion as a share of revenue.

Gross Operating Net FCF

Cash flow trend

CapEx is shown as a positive investment outflow; FCF equals CFO less CapEx.

Operating cash flow CapEx Free cash flow

Balance sheet trend

Period-end cash, total debt, and stockholders’ equity.

Cash Debt Equity